How big is the custom antibody industry?

The global custom antibody market size is expected to increase USD 444.66 million by 2033 from USD 175.70 million in 2023. Read More

What is the growth rate of the custom antibody industry?

The custom antibody market is anticipated to grow at a CAGR of over 9.73% between 2024 and 2033 Read More

Who are the prominent players operating in the custom antibody market?

The major players operating in the custom antibody market are GenScript, LifeSpan BioSciences, Inc, Labcorp Drug Development, Abmart, YenZym Antibodies, LLC., Kaneka Eurogentec S.A., Bio-Rad Laboratories, Inc, Abcam plc, Creative Diagnostics, Thermo Fisher Scientific Inc., and Others. Read More

Which are the driving factors of the custom antibody market?

The driving factors of the custom antibody market are the industry and academia collaboration and rising investment in life-science research like drug development, proteomics, and genomics. Read More

Which region will lead the global custom antibody market?

North America region will lead the global custom antibody market during the forecast period 2024 to 2033. Read More

Custom Antibody Market Size, Share, and Trends 2024 to 2033

Custom Antibody Market (By Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Others; By Service: Antibody Development, Antibody Production & Purification, Antibody Fragmentation & Labeling; By Source: Mice, Rabbit, Others; By Application: Oncology, Infectious Diseases, Neurology, Stem Cells, Immunology, Cardiovascular Diseases, Others; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Last Updated : June 2024
Report Code : 4562
Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Custom Antibody Market

5.1. COVID-19 Landscape: Custom Antibody Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Custom Antibody Market, By Type

8.1. Custom Antibody Market, by Type, 2024-2033

8.1.1. Monoclonal Antibodies

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Polyclonal Antibodies

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Recombinant Antibodies

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Custom Antibody Market, By Service

9.1. Custom Antibody Market, by Service, 2024-2033

9.1.1. Antibody Development

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Antibody Production & Purification

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Antibody Fragmentation & Labeling

9.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Custom Antibody Market, By Source

10.1. Custom Antibody Market, by Source, 2024-2033

10.1.1. Mice

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Rabbit

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Others

10.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Custom Antibody Market, By Application

11.1. Custom Antibody Market, by Application, 2024-2033

11.1.1. Oncology

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Infectious Diseases

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Neurology

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Stem Cells

11.1.4.1. Market Revenue and Forecast (2021-2033)

11.1.5. Immunology

11.1.5.1. Market Revenue and Forecast (2021-2033)

11.1.6. Cardiovascular Diseases

11.1.6.1. Market Revenue and Forecast (2021-2033)

11.1.7. Others

11.1.7.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Custom Antibody Market, By End-use

12.1. Custom Antibody Market, by End-use, 2024-2033

12.1.1. Pharmaceutical & Biotechnology Companies

12.1.1.1. Market Revenue and Forecast (2021-2033)

12.1.2. Academic & Research Institutes

12.1.2.1. Market Revenue and Forecast (2021-2033)

12.1.3. CRO

12.1.3.1. Market Revenue and Forecast (2021-2033)

12.1.4. Hospitals and Clinics

12.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 13. Global Custom Antibody Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type (2021-2033)

13.1.2. Market Revenue and Forecast, by Service (2021-2033)

13.1.3. Market Revenue and Forecast, by Source (2021-2033)

13.1.4. Market Revenue and Forecast, by Application (2021-2033)

13.1.5. Market Revenue and Forecast, by End-use (2021-2033)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type (2021-2033)

13.1.6.2. Market Revenue and Forecast, by Service (2021-2033)

13.1.6.3. Market Revenue and Forecast, by Source (2021-2033)

13.1.6.4. Market Revenue and Forecast, by Application (2021-2033)

13.1.6.5. Market Revenue and Forecast, by End-use (2021-2033)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Type (2021-2033)

13.1.7.2. Market Revenue and Forecast, by Service (2021-2033)

13.1.7.3. Market Revenue and Forecast, by Source (2021-2033)

13.1.7.4. Market Revenue and Forecast, by Application (2021-2033)

13.1.7.5. Market Revenue and Forecast, by End-use (2021-2033)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type (2021-2033)

13.2.2. Market Revenue and Forecast, by Service (2021-2033)

13.2.3. Market Revenue and Forecast, by Source (2021-2033)

13.2.4. Market Revenue and Forecast, by Application (2021-2033)

13.2.5. Market Revenue and Forecast, by End-use (2021-2033)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type (2021-2033)

13.2.6.2. Market Revenue and Forecast, by Service (2021-2033)

13.2.6.3. Market Revenue and Forecast, by Source (2021-2033)

13.2.7. Market Revenue and Forecast, by Application (2021-2033)

13.2.8. Market Revenue and Forecast, by End-use (2021-2033)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type (2021-2033)

13.2.9.2. Market Revenue and Forecast, by Service (2021-2033)

13.2.9.3. Market Revenue and Forecast, by Source (2021-2033)

13.2.10. Market Revenue and Forecast, by Application (2021-2033)

13.2.11. Market Revenue and Forecast, by End-use (2021-2033)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type (2021-2033)

13.2.12.2. Market Revenue and Forecast, by Service (2021-2033)

13.2.12.3. Market Revenue and Forecast, by Source (2021-2033)

13.2.12.4. Market Revenue and Forecast, by Application (2021-2033)

13.2.13. Market Revenue and Forecast, by End-use (2021-2033)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type (2021-2033)

13.2.14.2. Market Revenue and Forecast, by Service (2021-2033)

13.2.14.3. Market Revenue and Forecast, by Source (2021-2033)

13.2.14.4. Market Revenue and Forecast, by Application (2021-2033)

13.2.15. Market Revenue and Forecast, by End-use (2021-2033)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type (2021-2033)

13.3.2. Market Revenue and Forecast, by Service (2021-2033)

13.3.3. Market Revenue and Forecast, by Source (2021-2033)

13.3.4. Market Revenue and Forecast, by Application (2021-2033)

13.3.5. Market Revenue and Forecast, by End-use (2021-2033)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type (2021-2033)

13.3.6.2. Market Revenue and Forecast, by Service (2021-2033)

13.3.6.3. Market Revenue and Forecast, by Source (2021-2033)

13.3.6.4. Market Revenue and Forecast, by Application (2021-2033)

13.3.7. Market Revenue and Forecast, by End-use (2021-2033)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type (2021-2033)

13.3.8.2. Market Revenue and Forecast, by Service (2021-2033)

13.3.8.3. Market Revenue and Forecast, by Source (2021-2033)

13.3.8.4. Market Revenue and Forecast, by Application (2021-2033)

13.3.9. Market Revenue and Forecast, by End-use (2021-2033)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type (2021-2033)

13.3.10.2. Market Revenue and Forecast, by Service (2021-2033)

13.3.10.3. Market Revenue and Forecast, by Source (2021-2033)

13.3.10.4. Market Revenue and Forecast, by Application (2021-2033)

13.3.10.5. Market Revenue and Forecast, by End-use (2021-2033)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type (2021-2033)

13.3.11.2. Market Revenue and Forecast, by Service (2021-2033)

13.3.11.3. Market Revenue and Forecast, by Source (2021-2033)

13.3.11.4. Market Revenue and Forecast, by Application (2021-2033)

13.3.11.5. Market Revenue and Forecast, by End-use (2021-2033)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type (2021-2033)

13.4.2. Market Revenue and Forecast, by Service (2021-2033)

13.4.3. Market Revenue and Forecast, by Source (2021-2033)

13.4.4. Market Revenue and Forecast, by Application (2021-2033)

13.4.5. Market Revenue and Forecast, by End-use (2021-2033)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type (2021-2033)

13.4.6.2. Market Revenue and Forecast, by Service (2021-2033)

13.4.6.3. Market Revenue and Forecast, by Source (2021-2033)

13.4.6.4. Market Revenue and Forecast, by Application (2021-2033)

13.4.7. Market Revenue and Forecast, by End-use (2021-2033)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type (2021-2033)

13.4.8.2. Market Revenue and Forecast, by Service (2021-2033)

13.4.8.3. Market Revenue and Forecast, by Source (2021-2033)

13.4.8.4. Market Revenue and Forecast, by Application (2021-2033)

13.4.9. Market Revenue and Forecast, by End-use (2021-2033)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type (2021-2033)

13.4.10.2. Market Revenue and Forecast, by Service (2021-2033)

13.4.10.3. Market Revenue and Forecast, by Source (2021-2033)

13.4.10.4. Market Revenue and Forecast, by Application (2021-2033)

13.4.10.5. Market Revenue and Forecast, by End-use (2021-2033)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type (2021-2033)

13.4.11.2. Market Revenue and Forecast, by Service (2021-2033)

13.4.11.3. Market Revenue and Forecast, by Source (2021-2033)

13.4.11.4. Market Revenue and Forecast, by Application (2021-2033)

13.4.11.5. Market Revenue and Forecast, by End-use (2021-2033)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type (2021-2033)

13.5.2. Market Revenue and Forecast, by Service (2021-2033)

13.5.3. Market Revenue and Forecast, by Source (2021-2033)

13.5.4. Market Revenue and Forecast, by Application (2021-2033)

13.5.5. Market Revenue and Forecast, by End-use (2021-2033)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type (2021-2033)

13.5.6.2. Market Revenue and Forecast, by Service (2021-2033)

13.5.6.3. Market Revenue and Forecast, by Source (2021-2033)

13.5.6.4. Market Revenue and Forecast, by Application (2021-2033)

13.5.7. Market Revenue and Forecast, by End-use (2021-2033)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type (2021-2033)

13.5.8.2. Market Revenue and Forecast, by Service (2021-2033)

13.5.8.3. Market Revenue and Forecast, by Source (2021-2033)

13.5.8.4. Market Revenue and Forecast, by Application (2021-2033)

13.5.8.5. Market Revenue and Forecast, by End-use (2021-2033)

Chapter 14. Company Profiles

14.1. GenScript

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. LifeSpan BioSciences, Inc

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Labcorp Drug Development

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Abmart

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. YenZym Antibodies, LLC.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Kaneka Eurogentec S.A.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Bio-Rad Laboratories, Inc

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Abcam plc

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Creative Diagnostics

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Thermo Fisher Scientific Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

We use cookies to improve your experience

Custom Antibody Market Size to Hit USD 444.66 Million by 2033

List of Contents